We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

7 hedge funds and large institutions have $3.31M invested in Eterna Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $2.66M → $3.31M (+$650K)

17% more funds holding

Funds holding: 6 → 7 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$113K

Top Sellers

Rank Fund Capital Flow
1
MHP
Manatuck Hill Partners
Connecticut
-$226K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$113K
3
RJA
Raymond James & Associates
Florida
-$45K
4
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$30K
5
OC
Oppenheimer & Co
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$1.56M – – –
EAM
2
Eagle Asset Management
Florida
$775K – – –
MHP
3
Manatuck Hill Partners
Connecticut
$258K -$226K -2 -50%
Goldman Sachs
4
Goldman Sachs
New York
$192K +$113K +1 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$182K -$113K -1 -50%
Renaissance Technologies
6
Renaissance Technologies
New York
$158K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$143K – – –
BIT
8
BlackRock Institutional Trust
California
$22K – – –
BFA
9
BlackRock Fund Advisors
California
$3K – – –
JP Morgan Chase
10
JP Morgan Chase
New York
$3K – – –
UBS Group
11
UBS Group
Switzerland
$3K – – –
IIC
12
Integrated Investment Consultants
Michigan
$2K – – –
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Manulife (Manufacturers Life Insurance)
14
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
ADL
15
Asset Dedication LLC
California
– -$1K – –
Northern Trust
16
Northern Trust
Illinois
– -$4K – –
OC
17
Oppenheimer & Co
New York
– -$7K – –
RJA
18
Raymond James & Associates
Florida
– -$45K – –
State of New Jersey Common Pension Fund D
19
State of New Jersey Common Pension Fund D
New Jersey
– -$30K – –

ERNA Hedge Fund Activity: Q2 2016 in Review

7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2016, worth a combined $3.31M — up 24% from $2.66M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ERNA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $113K. The largest seller was Manatuck Hill Partners, cutting an estimated $226K.

  • 7 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2016, up from 6 in Q1 2016.
  • Funds reported $3.31M of Eterna Therapeutics stock for Q2 2016, up 24% quarter-over-quarter.
  • 1 fund opened new Eterna Therapeutics positions in Q2 2016 and 0 closed out, a net change of +1 holder.
  • The largest Eterna Therapeutics buyer in Q2 2016 was Goldman Sachs, an estimated $113K added.
  • The largest Eterna Therapeutics seller in Q2 2016 was Manatuck Hill Partners, an estimated $226K sold.

Based on aggregated 13F filings for Q2 2016.